Tema Oncology ETF (CANC)
NASDAQ: CANC · Real-Time Price · USD
35.38
-0.25 (-0.70%)
At close: Dec 26, 2025, 4:00 PM EST
35.41
+0.03 (0.08%)
After-hours: Dec 26, 2025, 4:15 PM EST

CANC Holdings Information

CANC is an equity ETF with a total of 56 individual holdings. The top holdings are Revolution Medicines stock at 6.33%, Eli Lilly and Company at 5.23%, BridgeBio Pharma at 4.37%, AstraZeneca at 4.36%, and Novartis AG at 4.23%.

Total Holdings
56
Top 10 Percentage
43.18%
Asset Class
Equity
ETF Category
Health
Assets
118.37M
PE Ratio
19.80

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1RVMDRevolution Medicines, Inc.6.33%89,736
2LLYEli Lilly and Company5.23%5,597
3BBIOBridgeBio Pharma, Inc.4.37%65,719
4LON: AZNAstraZeneca PLC4.36%27,186
5SWX: NOVNNovartis AG4.23%34,915
6RHHBYRoche Holding AG4.06%88,898
7GMABGenmab A/S3.97%135,741
8COGTCogent Biosciences, Inc.3.59%104,096
9MRKMerck & Co., Inc.3.58%38,742
10EXELExelixis, Inc.3.46%85,564
11BMYBristol-Myers Squibb Company3.45%72,556
12NUVLNuvalent, Inc.3.28%35,695
13JNJJohnson & Johnson3.04%16,841
14ABBVAbbVie Inc.2.85%14,276
15CELCCelcuity Inc.2.43%27,237
16AMGNAmgen Inc.2.25%7,762
17ACLXArcellx, Inc.2.21%38,488
18ONCBeOne Medicines AG2.14%7,899
19IDYAIDEAYA Biosciences, Inc.2.13%68,658
20SNDXSyndax Pharmaceuticals, Inc.2.04%108,973
21NUVBNuvation Bio Inc.1.97%238,724
22IMNMImmunome, Inc.1.94%99,913
23LEGNLegend Biotech Corporation1.77%88,753
24ZYMEZymeworks Inc.1.73%74,379
25GILDGilead Sciences, Inc.1.50%13,779
Showing 25 of 56 holdings
Subscribe to see the full list
As of Dec 24, 2025